In addition, inhibition of GHR signaling sensitized breast cancer cells to chemotherapy by decreasing ABCG2, which resulted in lowering the drug effluxing capabilities of ER−ve breast cancer cells. The gene discussed is ABCG2; the disease is breast cancer.